Abstract
Purpose
To investigate the feasibility, strategy, and long-term outcome of percutaneous recanalization for combined-type Budd–Chiari syndrome (BCS).
Methods
From December 2007 to August 2014, consecutive symptomatic combined-type BCS patients were treated by percutaneous recanalization in our centers. Inferior vena cava (IVC) recanalization was the first-stage treatment for all patients. Recanalization of one hepatic vein (HV) was the second-stage treatment for the selected patients. If the patient had the compensatory and patent accessory HV (AHV), we observed this patient for 7 days after IVC recanalization. If the symptoms of portal hypertension improved, HV recanalization was not needed. Otherwise, HV recanalization was performed. If the patient had no patent AHV, HV recanalization was performed 3 days after IVC recanalization. Data on technical success, clinical success, and follow-up were analyzed, respectively.
Results
Sixty-two symptomatic combined-type BCS patients were enrolled. Technical success of percutaneous recanalization was achieved in 60 patients. Among them, 52 patients had the patent AHV and underwent single IVC recanalization, and 8 patients had no patent AHV and underwent combined IVC and HV recanalization. Clinical success was achieved in all of the 60 patients. Three patients died during the follow-up. The cumulative 1-, 2-, and 4-year survival rates were 98.3%, 96.5%, and 92.7%, respectively.
Conclusion
Percutaneous recanalization is suitable for most combined-type BCS patients. Treatment strategy can be made according to the situation of AHV. If the patient has the patent AHV, single IVC recanalization is enough. Otherwise, combined IVC and HV recanalization should be performed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Han G, Qi X, Zhang W, et al. (2013) Percutaneous recanalization for Budd-Chiari syndrome: an 11-year retrospective study on patency and survival in 177 Chinese patients from a single center. Radiology 266:657–667
Ding PX, Li YD, Han XW, et al. (2011) Treatment of Budd-Chiari syndrome with urokinase following predilation in patients with old inferior vena cava thrombosis. Radiol Med 116:56–60
Zhang Q, Huang Q, Shen B, et al. (2014) Efficacy and safety of endovascular intervention for the management of primary entire-inferior vena cava Occlusion. Cardiovasc Interv Radiol. doi:10.1007/s00270-014-0980-4
Zhang QQ, Xu H, Zu MH, et al. (2014) Strategy and long-term outcomes of endovascular treatment for Budd-Chiari syndrome complicated by inferior vena caval thrombosis. Eur J Vasc Endovasc Surg 47:550–557
Fitsiori K, Tsitskari M, Kelekis A, et al. (2014) Transjugular intrahepatic portosystemic shunt for the treatment of Budd-Chiari syndrome patients: results from a single center. Cardiovasc Interv Radiol 37:691–697
Zhang Q, Xu H, Zu M, et al. (2013) Catheter–directed thrombolytic therapy combined with angioplasty for hepatic vein obstruction in Budd-Chiari syndrome complicated by thrombosis. Exp Ther Med 6:1015–1021
Sang HF, Li XQ (2014) Endovascular treatment of Budd-Chiari syndrome with hepatic vein obstruction in China. J Laparoendosc Adv Surg Tech A 24:846–851
Eapen CE, Velissaris D, Heydtmann M, et al. (2006) Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut 55:878–884
Zhang CQ, Fu LN, Xu L, et al. (2003) Long-term effect of stent placement in 115 patients with Budd-Chiari syndrome. World J Gastroenterol 9:2587–2591
Fu YF, Wei N, Wu Q, et al. (2015) Use of accessory hepatic vein intervention in the treatment of Budd-Chiari syndrome. Cardiovasc Interv Radiol. doi:10.1007/s00270-015-1105-4
Kathuria R, Srivastava A, Yachha SK, et al. (2014) Budd-Chiari syndrome in children: clinical features, percutaneous radiological intervention, and outcome. Eur J Gastroenterol Hepatol 26:1030–1038
Fu YF, Xu H, Zhang K, et al. (2015) Accessory hepatic vein recanalization for treatment of Budd-Chiari syndrome due to long-segment obstruction of the hepatic vein: initial clinical experience. Diagn Interv Radiol 21:148–153
Tang W, Zhang XM, Yang L, et al. (2011) Hepatic caudate vein in Budd-Chiari syndrome: depiction by using magnetic resonance imaging. Eur J Radiol 77:143–148
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.
This article does not contain any studies with animals performed by any of the authors.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Yu-Fei Fu and Yu Li have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Fu, YF., Li, Y., Cui, YF. et al. Percutaneous recanalization for combined-type Budd–Chiari syndrome: strategy and long-term outcome. Abdom Imaging 40, 3240–3247 (2015). https://doi.org/10.1007/s00261-015-0496-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-015-0496-7